PHR3041 Comprehensive care: Blood, brain and cancers

When you finish this unit, you should be able to:

1. 1

   Describe the pathophysiology of selected blood and brain conditions, and cancers 

2. 2

   Describe the epidemiology and clinical aspects of disease state management for selected blood and brain conditions, and cancers

3. 3

   Describe the signs and symptoms, and diagnostic methods relevant to a variety of blood and brain conditions, and cancers 

4. 4

   Explain the molecular basis of drug action and/or the mechanism of action of drugs used in treatment of selected blood and brain conditions, and cancers, and predict how this leads to the treatment of disease and possible side effects 

5. 5

   In the context of a pharmacist and a standardised approach to patient centred care (e.g. Monash Model of CARE) in patients' with a blood or brain condition and/or cancer: 
   (i) Gather and integrate information concerning the chemistry and pharmacology of medicines, in addition to pharmacokinetic and patient specific factors, to identify potential management options 
   (ii) Create a medication management plan which incorporates established clinical guidelines and a comprehensive clinical review of their medicine-related problems
   (iii) List and prioritise drug and non-drug therapy options for condition management 
   (iv) Evaluate and justify when referral for medical assessment is required, with a particular emphasis on symptoms indicative of referral
   (v) Develop, apply and communicate education strategies that provide support and optimise patient-centred relationships and outcomes

6. 6

   Reflect on the development and implementation of the Monash model of CARE plan and the development of other skills relevant to pharmacy practice.

7. 7

   Using a multidisciplinary healthcare team approach, develop and articulate appropriate clinical and communication strategies to treat selected blood and brain conditions, and cancers